THX-01 (Lead Candidate)

About THX Pharma

Theranexus is a mission-driven biotech focused on translating its proprietary drug discovery platform into treatments for rare neurological diseases, beginning with Batten disease. Its key achievement is establishing a clinically validated platform born from prestigious CEA research, now yielding a lead candidate in active development. The company's strategy is to systematically de-risk drug discovery in complex neurology, aiming to build a sustainable pipeline addressing severe orphan indications. As a public entity, it seeks to leverage capital markets to advance its programs through critical clinical milestones.

Therapeutic Areas